ATE197307T1 - Neuroaktive peptide - Google Patents
Neuroaktive peptideInfo
- Publication number
- ATE197307T1 ATE197307T1 AT97927691T AT97927691T ATE197307T1 AT E197307 T1 ATE197307 T1 AT E197307T1 AT 97927691 T AT97927691 T AT 97927691T AT 97927691 T AT97927691 T AT 97927691T AT E197307 T1 ATE197307 T1 AT E197307T1
- Authority
- AT
- Austria
- Prior art keywords
- neuroactive peptides
- specific identification
- neuroactive
- peptides
- nmda
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/649,272 US5763393A (en) | 1996-05-17 | 1996-05-17 | Neuroactive peptides |
| PCT/US1997/008667 WO1997043306A1 (en) | 1996-05-17 | 1997-05-16 | Neuroactive peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE197307T1 true ATE197307T1 (de) | 2000-11-15 |
Family
ID=24604116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97927691T ATE197307T1 (de) | 1996-05-17 | 1997-05-16 | Neuroaktive peptide |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5763393A (de) |
| EP (2) | EP0914331B1 (de) |
| JP (1) | JP2000501746A (de) |
| AT (1) | ATE197307T1 (de) |
| AU (1) | AU3209097A (de) |
| CA (1) | CA2255659C (de) |
| DE (1) | DE69703449T2 (de) |
| DK (1) | DK0914331T3 (de) |
| ES (1) | ES2153671T3 (de) |
| GR (1) | GR3035227T3 (de) |
| PT (1) | PT914331E (de) |
| WO (1) | WO1997043306A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001098367A2 (en) * | 2000-06-22 | 2001-12-27 | Nyxis Neurotherapies, Inc. | Neuroactive peptides for treatment of hypoxia and related conditions |
| WO2003010540A1 (en) * | 2001-07-25 | 2003-02-06 | Nyxis Neurotherapies, Inc. | Method of identifying nmda-related agent |
| KR101769999B1 (ko) | 2008-09-18 | 2017-08-21 | 노오쓰웨스턴 유니버시티 | Ｎｍｄａ 수용체 조절제 및 그의 용도 |
| US8951968B2 (en) | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
| PL2485751T3 (pl) | 2009-10-05 | 2014-10-31 | Univ Northwestern | GLYX-13 do stosowania w sposobie leczenia depresji opornej na leczenie |
| CA2789331C (en) | 2010-02-11 | 2017-11-07 | Northwestern University | Secondary structure stabilized nmda receptor modulators and uses thereof |
| KR101692275B1 (ko) | 2010-02-11 | 2017-01-04 | 노오쓰웨스턴 유니버시티 | ２차 구조 안정화된 ｎｍｄａ 수용체 조절제 및 그의 용도 |
| SG194230A1 (en) | 2011-04-27 | 2013-12-30 | Univ Northwestern | Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders |
| US8798716B1 (en) | 2011-11-03 | 2014-08-05 | Solstice Corporation | Fiducial markers and related methods |
| US8974365B2 (en) | 2012-11-25 | 2015-03-10 | Steven Richard Devore Best | Treatment of thalamocortical dysrhythmia |
| RS59687B1 (sr) | 2013-01-22 | 2020-01-31 | Vistagen Therapeutics Inc | Oblici doziranja i terapeutske primene l-4-hlorkinurenina |
| MX2015009773A (es) | 2013-01-29 | 2016-08-05 | Aptinyx Inc | Moduladores de receptores nmda de espiro-lactama y sus usos. |
| PE20151436A1 (es) | 2013-01-29 | 2015-10-10 | Naurex Inc | Moduladores de receptores nmda de espiro-lactama y sus usos |
| CA2899010A1 (en) | 2013-01-29 | 2014-08-07 | Naurex, Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| BR112015018087B1 (pt) | 2013-01-29 | 2022-09-20 | Aptinyx Inc | Compostos moduladores de receptor n-metil-d-aspartato (nmda) de espiro-lactama, composição farmacêutica e uso dos mesmos |
| JP6531042B2 (ja) | 2013-01-29 | 2019-06-12 | アプティニックス インコーポレイテッド | スピロラクタム系ｎｍｄａ受容体モジュレーターおよびその使用 |
| GB201319437D0 (en) * | 2013-11-04 | 2013-12-18 | Nanomerics Ltd | Delivery of drugs |
| RU2716164C2 (ru) | 2014-04-25 | 2020-03-06 | Наурекс, Инк. | Стабильные композиции нейроактивных пептидов |
| JP2017525684A (ja) * | 2014-07-24 | 2017-09-07 | ノーレックス インコーポレイテッド | Ｎ−メチル−ｄ−アスパラギン酸受容体モジュレーターならびにその製造方法及び使用方法 |
| RU2017107033A (ru) | 2014-08-14 | 2018-09-14 | Наурекс, Инк. | Способы лечения депрессии с применением модуляторов nmda |
| PE20190174A1 (es) | 2016-05-19 | 2019-02-01 | Aptinyx Inc | Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos |
| WO2017201285A1 (en) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| AU2017306152A1 (en) | 2016-08-01 | 2019-01-31 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
| US10918637B2 (en) | 2016-08-01 | 2021-02-16 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
| SG11201900554YA (en) | 2016-08-01 | 2019-02-27 | Aptinyx Inc | Spiro-lactam nmda modulators and methods of using same |
| CN109661398B (zh) | 2016-08-01 | 2022-07-05 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺和二-螺-内酰胺nmda受体调节剂及其用途 |
| BR112019001921A2 (pt) | 2016-08-01 | 2019-05-14 | Aptinyx Inc. | moduladores do receptor nmda de espiro-lactama e seus usos |
| US20190351006A1 (en) | 2017-11-10 | 2019-11-21 | Naurex Inc. | Methods of administration of nmda receptor agonists |
| KR20200096946A (ko) | 2017-12-05 | 2020-08-14 | 노렉스, 인크. | 조합된 치료(수면 및 cns 장애)용 nmda 수용체 조절자(라파스티넬) 조합물 |
| US11578072B2 (en) | 2018-01-31 | 2023-02-14 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
| US12012413B2 (en) | 2019-11-11 | 2024-06-18 | Tenacia Biotechnology (Hong Kong) Co., Limited | Methods of treating painful diabetic peripheral neuropathy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5854217A (en) * | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
| US5428069A (en) * | 1993-01-11 | 1995-06-27 | The United States Of America As Represented By The Department Of Health & Human Services | Treating cognition with, aminocyclopropanecarboxylic derivatives |
| JPH07101999A (ja) * | 1993-10-06 | 1995-04-18 | Hagiwara Yoshihide | 抗癌ヒトモノクローナル抗体に対する抗イデイオタイプ抗体のアミノ酸配列およびそれをコードするｄｎａ塩基配列 |
-
1996
- 1996-05-17 US US08/649,272 patent/US5763393A/en not_active Expired - Lifetime
-
1997
- 1997-05-16 AU AU32090/97A patent/AU3209097A/en not_active Abandoned
- 1997-05-16 ES ES97927691T patent/ES2153671T3/es not_active Expired - Lifetime
- 1997-05-16 JP JP9541206A patent/JP2000501746A/ja not_active Ceased
- 1997-05-16 WO PCT/US1997/008667 patent/WO1997043306A1/en not_active Ceased
- 1997-05-16 AT AT97927691T patent/ATE197307T1/de not_active IP Right Cessation
- 1997-05-16 EP EP97927691A patent/EP0914331B1/de not_active Expired - Lifetime
- 1997-05-16 EP EP00118013A patent/EP1077217A3/de not_active Withdrawn
- 1997-05-16 DE DE69703449T patent/DE69703449T2/de not_active Expired - Fee Related
- 1997-05-16 CA CA002255659A patent/CA2255659C/en not_active Expired - Lifetime
- 1997-05-16 PT PT97927691T patent/PT914331E/pt unknown
- 1997-05-16 DK DK97927691T patent/DK0914331T3/da active
-
1998
- 1998-06-08 US US09/105,799 patent/US6107271A/en not_active Expired - Fee Related
-
2001
- 2001-01-11 GR GR20010400043T patent/GR3035227T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1077217A3 (de) | 2004-01-02 |
| EP0914331A1 (de) | 1999-05-12 |
| GR3035227T3 (en) | 2001-04-30 |
| ES2153671T3 (es) | 2001-03-01 |
| DE69703449T2 (de) | 2001-06-07 |
| PT914331E (pt) | 2001-04-30 |
| US6107271A (en) | 2000-08-22 |
| CA2255659A1 (en) | 1997-11-20 |
| EP1077217A2 (de) | 2001-02-21 |
| CA2255659C (en) | 2005-03-15 |
| AU3209097A (en) | 1997-12-05 |
| DE69703449D1 (de) | 2000-12-07 |
| JP2000501746A (ja) | 2000-02-15 |
| EP0914331B1 (de) | 2000-11-02 |
| WO1997043306A1 (en) | 1997-11-20 |
| DK0914331T3 (da) | 2001-02-12 |
| US5763393A (en) | 1998-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE197307T1 (de) | Neuroaktive peptide | |
| CY1114164T1 (el) | Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου | |
| FI974429L (fi) | Suspendoituja peptidi/proteiinivalmisteita | |
| EA200100447A1 (ru) | Гибридные белки на основе бета-интерферона и их применение | |
| BR0009206A (pt) | Isolamento e análise de proteina | |
| DE69739245D1 (de) | System zur Identifizierung von Material mittels NIR-Spektrometrie | |
| ATE410441T1 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen | |
| DE69739219D1 (de) | Peptide und zusammensetzungen, die an den thrombopoietin-rezeptor binden | |
| ES2149149T1 (es) | Proteinas de fijacion de interleuquina-18, su preparacion y utilizacion. | |
| TR199700714A2 (xx) | Paratiroit hormonu, analoglar�n�n sentezi i�in bir y�ntem. | |
| DE69715181D1 (de) | Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator | |
| AU9744898A (en) | Synthetic polypeptide for diagnosing and treating prion-related diseases | |
| EP1061935A4 (de) | Proapoptotische peptide, abhängigkeitspolypeptide und methoden zu deren verwendung | |
| ATE225806T1 (de) | D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet | |
| GB9816514D0 (en) | Novel method | |
| DE69939833D1 (de) | Neues tumor-antigen-protein sart-3 und tumor-antigen-peptid davon | |
| DE69704269D1 (de) | Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung | |
| ATE385805T1 (de) | Neue peptide | |
| AU2172597A (en) | Protein phosphatase-1 catalytic subunit interactions | |
| AU5692699A (en) | Apparatus for rapid protein and polypeptide sequence analysis | |
| NO20005081D0 (no) | Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav | |
| DE69738600D1 (de) | Neuroaktive peptide | |
| DE69632535D1 (de) | Peptide zur detektion von hiv-1 | |
| CA2140091A1 (en) | Peptides and antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2 | |
| DK0792291T3 (da) | Protein, der påvirker KATP-kanaler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |